«Factor Xiiia

Below is an extended Factor Xiiia patents listing. Click here to return to the Factor Xiiia main in depth entry.

Patents :
US Patent No.	Title
7125846	Pharmaceutical composition comprising factor VII polypeptides and factor V polypeptides
7196180	Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same
7198776	Metal complex compounds
7208138	Contrast enhancement agent for magnetic resonance imaging
7208179	Methods for treating disease and forming a supplemented fibrin matrix
7211650	Purification of fibrinogen from fluids by precipitation and hydrophoic chromatography
7220556	Preparation of factor XIIIa by gene manipulation
7229959	Supplemented fibrin matrix delivery systems
7241603	Method for producing a preparation based on fibrinogen and fibronectin as well as protein compositions obtainable according to this method
7241730	Enzyme-mediated modification of fibrin for tissue engineering: fibrin formulations with peptides
7247303	Selected antibody CDRs for binding to aminophospholipids
7196054	Methods for treating wound tissue and forming a supplemented fibrin matrix
7189829	Baboon TAFI polypeptides
7189410	Supplemented and unsupplemented tissue sealants, methods of their production and use
7128912	Fibronectin binding protein compositions and methods of use
7138245	FXIII detection for verifying serum sample and sample size and for detecting dilution
7141362	FXIII detection for verifying serum sample and sample size and for detecting dilution
7141428	Methods for making and delivering rho-antagonist tissue adhesive formulations to the injured mammalian central and peripheral nervous systems and uses thereof
7156835	Method of applying composition to a surface
7169572	Assays for determining anticoagulant cofactor activity
7169573	Method for monitoring coagulability and hypercoagulable states
7179604	Methods of use of DNA encoding a human histamine receptor of the H3 subtype
7179652	Protocol for monitoring platelet inhibition
7186803	Human vanilloid receptor VR3 protein
7247609	Growth factor modified protein matrices for tissue engineering
7252799	Methods for sterilizing preparations containing albumin
7371729	Boronic acid salts useful in parenteral formulations
7374774	Electroprocessed material made by simultaneously electroprocessing a natural protein polymer and two synthetic polymers
7378386	Anti-viral treatment methods using phosphatidylethanolamine-binding peptide derivatives
7381536	Assessment of cardiac health and thrombotic risk in a patient
7384909	Anti-viral treatment methods using phosphatidylethanolamine-binding peptides linked to anti-viral agents
7390526	Methods and materials for nanocrystalline surface coatings and attachment of peptide amphiphile nanofibers thereon
7399483	Carrier with solid fibrinogen and solid thrombin
7407982	Oligo or polyalkylene glycol-coupled thrombin inhibitors
7411051	Antibodies to HDPPA04 polypeptide
7412977	Methods and devices for inducing collapse in lung regions fed by collateral pathways
7371722	Pharmaceutical preparations and medicine capable of generating and/or containing thrombin
7371719	Self-assembly of peptide-amphiphile nanofibers under physiological conditions
7368531	Human secreted proteins
7285580	Methods of using primer molecules for enhancing the mechanical performance of tissue adhesives and sealants
7291587	Pharmaceutical composition comprising factor VII polypeptides and TAFI polypeptides
7300428	Tissue volume reduction
7300922	Modulators of pharmacological agents
7329402	Methods of imaging and treatment
7335733	Tissue cement proteins from Rhipicephalus appendiculatus
7358055	Diagnostic markers of acute coronary syndrome and methods of use thereof
7361473	Diagnostic markers of acute coronary syndrome and methods of use thereof
7361663	N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor Xa
7368527	HADDE71 polypeptides
7423013	Protein formulation

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.